Robert Young Kim
Chief Medical Officer, 4D Molecular Therapeutics, Inc.
Companies
- 4D Molecular Therapeutics, Inc.Chief Medical Officer Apr 5, 2023 to Mar 10, 20251
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
4D Molecular Therapeutics, Inc. FDMT1,595 shares2$19.4K at $12.14Feb 7, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 5, 2024Sold 552 shares at $30.05 of 4D Molecular Therapeutics, Inc.3
- Feb 5, 2024Sold 6,000 shares at $30.05 of 4D Molecular Therapeutics, Inc.3
- Feb 5, 2024Exercised options 6,000 shares at $8.04 of 4D Molecular Therapeutics, Inc.3
- Feb 5, 2024Sold 6,000 shares at $30.05 of 4D Molecular Therapeutics, Inc.3
- Feb 5, 2024Exercised options 6,000 shares at $15.78 of 4D Molecular Therapeutics, Inc.3
- Feb 5, 2024Sold 12,000 shares at $30.05 of 4D Molecular Therapeutics, Inc.3
- Feb 5, 2024Exercised options 12,000 shares at $18.66 of 4D Molecular Therapeutics, Inc.3
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Feb 7, 2024